DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,752,979 | -10.4% | 12,763 | -0.3% | 0.76% | -8.8% |
| Q2 2023 | $3,071,760 | -27.4% | 12,799 | -23.7% | 0.83% | -27.3% |
| Q1 2023 | $4,230,239 | +3.0% | 16,784 | +3.2% | 1.14% | -4.4% |
| Q4 2022 | $4,107,507 | -6.8% | 16,268 | +2.7% | 1.20% | -12.4% |
| Q3 2022 | $4,405,000 | +11.5% | 15,842 | +5.6% | 1.37% | +15.2% |
| Q2 2022 | $3,951,000 | -16.6% | 14,999 | -8.4% | 1.19% | +12.7% |
| Q1 2022 | $4,738,000 | -13.7% | 16,376 | -1.9% | 1.05% | -8.7% |
| Q4 2021 | $5,493,000 | +9.2% | 16,695 | +0.4% | 1.15% | -3.6% |
| Q3 2021 | $5,032,000 | +9.9% | 16,630 | -2.5% | 1.20% | +4.7% |
| Q2 2021 | $4,577,000 | +20.0% | 17,055 | +0.7% | 1.14% | +10.7% |
| Q1 2021 | $3,813,000 | -1.2% | 16,939 | +5.2% | 1.03% | -7.5% |
| Q4 2020 | $3,859,000 | +9.5% | 16,100 | -1.7% | 1.12% | -10.4% |
| Q3 2020 | $3,525,000 | +28.8% | 16,372 | +9.5% | 1.24% | +15.0% |
| Q2 2020 | $2,736,000 | +33.9% | 14,952 | +6.1% | 1.08% | +3.0% |
| Q1 2020 | $2,044,000 | -13.0% | 14,087 | -8.0% | 1.05% | +15.0% |
| Q4 2019 | $2,350,000 | +15.4% | 15,313 | +3.1% | 0.91% | -2.1% |
| Q3 2019 | $2,037,000 | -2.1% | 14,849 | +2.0% | 0.93% | +0.8% |
| Q2 2019 | $2,081,000 | +12.1% | 14,559 | +3.5% | 0.93% | +6.9% |
| Q1 2019 | $1,857,000 | +39.1% | 14,064 | +8.7% | 0.87% | +7.0% |
| Q4 2018 | $1,335,000 | – | 12,942 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |